Christopher J. Nardo - Jan 4, 2024 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
Senior VP, CDO
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Stock symbol
DRMA
Transactions as of
Jan 4, 2024
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 09:01 PM
Previous filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Stock Option (right to buy Award $0 +50K $0.00 50K Jan 4, 2024 Common Stock 50K $0.61 Direct F1

Explanation of Responses:

Id Content
F1 The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.